9 METERS BIOPHARMA, INC.: debt financing — 9 Meters Biopharma enters forbearance on convertible note; pays $3.1M partial acceleration after Nasdaq default

9 METERS BIOPHARMA, INC.

Partial acceleration of $3.1M paid to High Trail; outstanding principal reduced to ~$2.29M.
Forbearance period ends May 16, 2023, or earlier if Nasdaq delisting or other default occurs.
Restricted reserve account increased to $1.6M; default interest rate of 18% applied.
Company must deliver Nasdaq compliance plan by May 15, 2023.
Noteholder retains all remedies after forbearance terminates.

item 1.01 item 2.04 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

9 METERS BIOPHARMA, INC. faced acceleration on convertible notes of $3.1 million at 18.0%.

Instrument: convertible notes
Principal: $3.1 million
Rate: 18.0%
Event: acceleration

Exact text from the filing

On April 26, 2023, the Company entered into a forbearance agreement (the “Forbearance Agreement”) with the Holder, pursuant to which the Holder agreed to forbear from enforcing its full remedies related to the Existing Default until the earliest of (i) May 16, 2023, (ii) the occurrence of a default (other than the Existing Default) under the Note or related Note transaction documents, (iii) the Company receives notice from Nasdaq that its compliance plan is not accepted, or the Company’s common stock is delisted or halted from trading for more than one trading day, or (iv) the occurrence of a breach by the Company or its subsidiary of any of the representations, warranties, agreements or covenants. In exchange for the Holder agreeing to enter the Forbearance Agreement, the Company agreed to pay to the Holder a partial acceleration amount of approximately $3.1 million in cash, the restricted amount maintained in a reserve account under the terms of the Note was increased to $1.6 million

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0001551986-23-000028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.